RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Rezolute, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 24, 2026
$3.70+0.12 (+3.35%)
Close on Oct 19, 2026
- Market cap
- $386.60M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Rezolute has not reported a dividend
No dividend per share appears in Rezolute's annual filings since fiscal 2010.